Your browser doesn't support javascript.
loading
Efficacy of Coil Embolization in Small, Anterior Circulation Aneurysms in Patients Less Than 40 Years Old.
Park, Dong Sun; Roh, Hong Gee; Chun, Young Il; Jeon, Yoo Sung.
Afiliación
  • Park DS; Department of Neurosurgery, Hanyang University Changwon Hanmaeum Hospital, Changwon 51139, Republic of Korea.
  • Roh HG; Department of Radiology, Konkuk University Medical Center, Seoul 05030, Republic of Korea.
  • Chun YI; Department of Neurosurgery, Konkuk University Medical Center, Seoul 05030, Republic of Korea.
  • Jeon YS; Department of Neurosurgery, Konkuk University Medical Center, Seoul 05030, Republic of Korea.
J Clin Med ; 13(16)2024 Aug 13.
Article en En | MEDLINE | ID: mdl-39200905
ABSTRACT

Background:

Ruptured and unruptured aneurysms are less common in younger individuals compared to older patients. Endovascular treatment has gained popularity over surgical options in the general population, but surgery remains the primary treatment for younger patients due to concerns about higher recurrence rates with endovascular procedures.

Methods:

This study compared the immediate and long-term outcomes of endovascular treatment in patients under 40 years with those aged 41-60. The study included 239 patients who underwent endovascular treatment for intracranial aneurysms, divided into two age groups under 40 and 41-60 years. The rates of immediate radiologic outcomes, complications, and recurrence were assessed.

Results:

The results showed successful aneurysm obliteration rates of 70.1% in the younger group and 64.0% in the older group. The complication rates were 1.5% in the younger group and 3.5% in the older group, with the older group experiencing more procedure-related complications, though this difference was not statistically significant. Long-term follow-up revealed recurrence rates of 23.2% in the younger group and 18.2% in the older group, with no significant difference.

Conclusions:

The study suggests that endovascular treatment is as effective and safe for patients under 40 years. Therefore, it may be considered an acceptable first-line treatment for younger patients, aligning its use with that in older populations.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2024 Tipo del documento: Article Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Clin Med Año: 2024 Tipo del documento: Article Pais de publicación: Suiza